These authors contributed equally to the work.
Steatohepatitis/Metabolic Liver Disease
Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice†‡
Article first published online: 4 DEC 2012
DOI: 10.1002/hep.25881
Copyright © 2012 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Lian, J., Wei, E., Wang, S. P., Quiroga, A. D., Li, L., Di Pardo, A., van der Veen, J., Sipione, S., Mitchell, G. A. and Lehner, R. (2012), Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice. Hepatology, 56: 2154–2162. doi: 10.1002/hep.25881
- †
Potential conflict of interest: Nothing to report.
- ‡
The Lipid Analysis Core received financial support from the Women and Children Health Research Institute. A. D. P. was supported by a studentship from the Alberta Heritage Foundation for Medical Research. A. D. Q. was supported by a fellowship from the Heart and Stroke Foundation of Canada. S. S. and R.L. are a Scholar and a Scientist, respectively, of the Alberta Heritage Foundation for Medical Research. S. S. is a Canada Research Chair in Neurobiology of Huntington Disease. This work was supported by operating grants from the Canadian Institutes of Health Research (69043 to R. L., 111219 to S. S., and 221920 to G. A. M.) and the Canadian Diabetes Association (to J. v. d. V.) and a Pfizer CardioVascular Award (to R. L.).
- §
These authors contributed equally to the work.
- ¶
fax: 780-492-3383
Publication History
- Issue published online: 4 DEC 2012
- Article first published online: 4 DEC 2012
- Accepted manuscript online: 18 JUN 2012 04:56AM EST
- Manuscript Accepted: 2 MAY 2012
- Manuscript Received: 8 NOV 2011
Funded by
- Women and Children Health Research Institute
- Alberta Heritage Foundation
- Heart and Stroke Foundation of Canada
- Alberta Heritage Foundation for Medical Research
- Canada Research Chair in Neurobiology of Huntington Disease
- Canadian Institutes of Health Research. Grant Numbers: 69043, 111219, 221920
- Canadian Diabetes Association
- Pfizer CardioVascular Award
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!

1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
